home / stock / tkno / tkno news

TKNO News and Press, Alpha Teknova Inc. From 05/23/23

Stock Information
Company Name: Alpha Teknova Inc.
Stock Symbol: TKNO
Market: NASDAQ
Website: teknova.com
Menu
TKNO TKNO Quote TKNO Short TKNO News TKNO Articles TKNO Message Board
Get TKNO Alerts

News, Short Squeeze, Breakout and More Instantly...
TKNO - RETA SFIX and CMPS are among after hour movers

2023-05-23 17:14:55 ET Gainers: Reata Pharmaceuticals ( RETA ) +10% . Urban Outfitters ( URBN ) +7% . COMPASS Pathways   ( CMPS ) +6% . Stitch Fix ( SFIX ) +5% . TScan Therapeutics ( TCRX ) +4% . Losers: PTC The...
TKNO - Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript

2023-05-13 13:57:06 ET Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Conference Call May 10, 2023, 05:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chie...

TKNO - Alpha Teknova GAAP EPS of -$0.31 misses by $0.01, revenue of $9.1M beats by $0.99M

2023-05-10 16:09:42 ET Alpha Teknova press release ( NASDAQ: TKNO ): Q1 GAAP EPS of -$0.31 misses by $0.01 . Revenue of $9.1M (-18.0% Y/Y) beats by $0.99M . Gross profit for the first quarter 2023 was $2.4 million, compared to $5.3 million in the first quarter ...

TKNO - Teknova Reports First Quarter 2023 Financial Results

First quarter 2023 total revenue was $9.1 million, up 16% sequentially Launch of proprietary AAV-Tek™ Solutions gene therapy product line Company reaffirms 2023 revenue guidance of $42-46 million HOLLISTER, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova,...
TKNO - Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting

HOLLISTER, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced the Co...

TKNO - Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023

HOLLISTER, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that t...

TKNO - Teknova Launches Proprietary AAV-Tek(TM) Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies

HOLLISTER, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Com...
TKNO - Teknova to Report First Quarter 2023 Financial Results on May 10, 2023

HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that...

TKNO - Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript

2023-03-15 20:04:06 ET Alpha Teknova, Inc. (TKNO) Q4 2022 Results Conference Call March 15, 2023 05:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matt Lowell - Chief Financ...

TKNO - Alpha Teknova GAAP EPS of -$0.47 misses by $0.13, revenue of $7.89M beats by $0.18M

2023-03-15 16:31:29 ET Alpha Teknova press release ( NASDAQ: TKNO ): Q4 GAAP EPS of -$0.47 misses by $0.13 . Revenue of $7.89M (-22.0% Y/Y) beats by $0.18M . Adjusted EBITDA for the fourth quarter 2022 was negative $8.1 million, compared to negative $3.4 millio...
Previous 10 Next 10